Evidence map›Paper›PMID 36470896›Full record

ArticleScientific reports2022

Vaccine hesitancy prospectively predicts nocebo side-effects following COVID-19 vaccination.

Yaakov S G Hoffman, Yafit Levin, Yuval Palgi, Robin Goodwin, Menachem Ben-Ezra, Lee Greenblatt-Kimron

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Is there still hesitancy towards SARS-CoV-2 vaccination among people with neurological disease- a survey of the NeuroCOVID-19 task force of the European Academy of Neurology.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yaakov S G HoffmanThe Interdisciplinary Department of Social Sciences, Bar-Ilan University, Ramat-Gan, Israel. hoffmay@gmail.com.ORCID 0000-0001-5158-012X
Yafit LevinSchool of Social Work and School of Education, Ariel University, Ariel, Israel.
Yuval PalgiDepartment of Gerontology, University of Haifa, Haifa, Israel.
Robin GoodwinDepartment of Psychology, Warwick University, Coventry, UK.
Menachem Ben-EzraSchool of Social Work, Ariel University, Ariel, Israel.
Lee Greenblatt-KimronSchool of Social Work, Ariel University, Ariel, Israel.

Funding

Internal Ariel University Grant RA2000000522.
6 · The paper itself

Abstract

The directionality between vaccine hesitancy and COVID-19 vaccine side-effects has not been hitherto examined. We hypothesized a nocebo effect, whereby vaccine hesitancy towards the second Pfizer vaccination dose predicts subsequent side-effects for a booster dose, beyond other effects. We expected these nocebo effects to be driven by (mis)information in males and prior experience in females. A representative sample of older adults (n = 756, mean age = 68.9 ± 3.43) were questioned in a typical cross-lagged design (wave 1 following a second Pfizer dose, wave 2 after their booster). As hypothesized, earlier vaccine hesitancy predicted subsequent booster side-effects for females (β = 0.10 p = 0.025, f

Indexed as

COVID-19Drug-Related Side Effects and Adverse ReactionsAgedCOVID-19 VaccinesFemaleHumansMaleNocebo EffectVaccinationVaccination HesitancyCOVID-19 Vaccines

Identifiers

PMID36470896
PMCPMC9722845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.